Ontology highlight
ABSTRACT: Importance
Optimal pharmacologic treatment for chronic sciatica (CS) is currently unclear. While gabapentin (GBP) and pregabalin (PGB) are both used to treat CS, equipoise exists. Nevertheless, pharmaceutical regulation authorities typically subsidize one drug over the other. This hinders interchange wherever the favored drug is either ineffective or ill-tolerated.Objective
To assess GBP vs PGB head to head for the treatment of CS.Design, setting, and participants
A preplanned interim analysis of a randomized, double-blind, double-dummy crossover trial of PGB vs GBP for management of CS at half the estimated final sample size was performed in a single-center, tertiary referral public hospital. A total of 20 patients underwent randomization from March 2016 to March 2
SUBMITTER: Robertson K
PROVIDER: S-EPMC6439871 | biostudies-literature | 2019 Jan
REPOSITORIES: biostudies-literature